Yazar "Ugras, Halil Ibrahim" seçeneğine göre listele
Listeleniyor 1 - 2 / 2
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Determination of the Properties of Medium-Density Fiberboards Produced Using Urea-Formaldehyde Resins Modified with Boron Compounds(North Carolina State Univ Dept Wood & Paper Sci, 2024) Arslan, Recai; Karacay, Ebru; Maraslioglu, Derya; Tanriverdi, Bilge Asian; Firat, Ebru; Tozluoglu, Ayhan; Ugras, Halil IbrahimEffects of adding different boron compounds to the urea-formaldehyde resin were evaluated relative to the physical, mechanical, and other properties of medium-density fiberboard (MDF). While the chemical addition of boric acid to the urea-formaldehyde resin increased the modulus of rupture and modulus of elasticity values of MDF boards, the physical and chemical additions of other boron compounds decreased those values. While there were no significant decreases in internal bond values, the chemical addition of boric acid and borax decahydrate to urea-formaldehyde resin increased the internal bond values of MDF boards. It was observed that in both types of addition, borax pentahydrate reduced the formaldehyde emission values of MDF boards the most and also reduced the burnt area by up to 30%. When the type of addition of boron compounds to urea-formaldehyde was compared, the addition of boron compounds at the resin formation stage showed better results in the properties of MDF boards than physical addition.Öğe Oxidative, Genotoxic and Cytotoxic Damage Potential of Novel Borenium and Borinium Compounds(Mdpi, 2023) Oguzkan, Sibel Bayil; Turkez, Hasan; Ugras, Halil Ibrahim; Tatar, Arzu; Mardinoglu, AdilIn this study, the biological properties of novel borenium and borinium compounds in terms of their oxidative, genotoxic, and cytotoxic effects were assessed on cultured human peripheral blood cells, as well as several types of cancer cells. Our results revealed that the borinium compounds yielded the best results in terms of supporting total antioxidant capacity (TAC). In fact, borenium 1, borenium 2, borenium 3, borinium 4, and borinium 5 compounds elevated TAC levels of cultured human blood cells at rates of 42.8%, 101.5%, 69.8%, 33.3%, and 49.2%, respectively. There were no statistically significant differences (p > 0.05) between the negative control and the groups treated with all borinium and borenium concentrations from the micronucleus (MN) and chromosome aberration (CA) assays, demonstrating the non-genotoxic effects. Moreover, borenium 1 (60.7% and 50.7%), borenium 2 (70.4% and 57.2%), borenium 3 (53.1% and 45.2%), borinium 4 (55.1% and 48.1%), and borinium 5 (51.0% and 36.1%) minimized the mitomycin C(MMC)-induced genotoxic damages at different rates as determined using CA and MN assays, respectively. Again, it was found that the borinium compounds exhibited higher cytotoxic activity on cancer cells when compared to borenium compounds. Consequently, in light of our in vitro findings, it was suggested that the novel borinium and borenium compounds could be used safely in pharmacology, cosmetics, and various medical fields due to their antioxidant and non-genotoxic features, as well as their cytotoxicity potential on cancer cells.